Technical analysis · daily indicators as of Nov 19, 2026
9.72
+0.33 (+3.51%)
In short
TRex Bio has fallen 36.2% in a month and is 41% below its 52-week high, after its results on 13 Nov (the share fell 21.2% on the day it reacted). It traded 1.7× its usual volume.
Price chart
Drag to measure a move, wheel or pinch to zoom
The verdict
The main signals
1-year return
-30.6%
Industry -34.6% · S&P 500 +8.4%
Daily price swing
13.7%
Calm 2.2%Wild 8.7%
Beta vs S&P 500
–
Not enough history
Dividend yield
–
Not known
Returns against the market
Last 7 days
TRex Bio
-31.1%Industry
-11.0%S&P 500
-5.5%
Last year
TRex Bio
-30.6%Industry
-34.6%S&P 500
+8.4%
Beat its industry (biological products, (no diagnostic substances)) and trailed the S&P 500 over the past year. Industry = the middle stock of the same SEC industry. Price returns, dividends not added back.
Green = best of the 5 shown, red = weakest; the rank shows where TRex Bio stands among them (1st = best). Industry middle = the middle value of all 162 companies in Biological Products, (No Diagnostic Substances).
Based on 3 common daily signals, TRex Bio, Inc.'s technical rating is "Strongly bearish". This is information only, not a recommendation.
What is the RSI of TRXB?
TRXB's 14-day RSI is 30.3 as of the 2026-11-19 close. Below 30 is usually called oversold and above 70 overbought.
What is TRex Bio, Inc.'s market cap and P/E?
Market cap $280 million, from today's price and the last 12 months of results filed with the SEC.
Technical ratings summarise common indicators for information only. They are not buy or sell recommendations.
How to read this page
The snapshot at the top sums up the company: its price, valuation and a score from 20 checks on four sides (value, past performance, financial health and dividends), with how the company compares with others in its industry. The chart shows the price with moving averages; the technical readings below (RSI, MACD, support and resistance) describe the trend and momentum.
The Fundamentals tab has the results from the company's SEC filings: revenue, profit, margins and growth, quarter by quarter. Foreign companies that report only once a year show yearly figures, converted to US dollars when they report in another currency. Use the results and filings to check whether a move is backed by the business.